Neuromodulatory Devices & Applications, Inc.

Neuromodulatory Devices & Applications, Inc., a subsidiary of San Diego-based Ampa Inc., manufactures and sells portable Transcranial Magnetic Stimulation (TMS) systems to the Department of Veterans Affairs and the Defense Health Agency as a prime contractor operating under full-and-open competition with no small business set-asides. The company is classified as a for-profit manufacturer of goods under NAICS 334517 (Electromedical and Electrotherapeutic Apparatus Manufacturing) and PSC 6515 (Medical and Surgical Instruments, Equipment, and Supplies).

Neuromodulatory Devices has earned three purchase orders totaling $545 thousand in combined potential value across the past six months. The largest award is a $369 thousand firm fixed-price purchase order from the Defense Health Agency for a TMS system with performance at Fort Gordon, Georgia and ultimate completion May 19, 2031. The Veterans Integrated Service Network 1 (VISN 1), the Department of Veterans Affairs regional office serving New England, awarded a $116.2 thousand purchase order on September 29, 2026 for a portable AMPA ONE TMS system to support inpatient psychiatric treatment at Providence VA Medical Center; the order specifies a generator not exceeding 45 pounds with integrated wheels, an L-coil under 12 pounds with camera-guided positioning, neuronavigation caps in four sizes, support for FDA-cleared iTBS and bilateral/dorsomedial prefrontal treatments, passive thermal management, and a tablet-based interface compliant with psychiatric inpatient safety requirements. A third purchase order from Veterans Integrated Service Network 21 valued at $60 thousand for the AMPA ONE SYSTEM was awarded September 15, 2026 with completion due November 30, 2026. The Defense Health Agency and VISN 1 award account for 100% of combined potential value. Two of the three awards (combined potential value $176 thousand) reach ultimate completion within the next twenty-four months and face recompete exposure in that window. Neuromodulatory Devices operates as a prime on all work; the source identifies no subcontract activity or parent-vehicle participation.